After a January 2007 publication revealed DCA (dichloroacetae) had anti cancer properties in animal studies researchers in Canada have now started a phase 2 clinical trial after Health Canada gave approval, rather than a phase 1 study.
Unlike other national organizations like the NRC or the Canadian Breast Cancer Foundation, Health Canada is backing this non profitable drug, great job Health Canada! If only a national organization would help with funding a drug that doesn't make American pharmaceutical companies rich now.
DCA is cheap and not patentable, so major pharmaceutical companies will not fund studies. The researchers for this phase 2 study needed to get personal donations from the general public totalling 800K.
P.Fezziwig, contributor for Healthcare Reviews , http://www.healthcarereviews.com , building a better healthcare system through patient feedback.
Unlike other national organizations like the NRC or the Canadian Breast Cancer Foundation, Health Canada is backing this non profitable drug, great job Health Canada! If only a national organization would help with funding a drug that doesn't make American pharmaceutical companies rich now.
DCA is cheap and not patentable, so major pharmaceutical companies will not fund studies. The researchers for this phase 2 study needed to get personal donations from the general public totalling 800K.
P.Fezziwig, contributor for Healthcare Reviews , http://www.healthcarereviews.com , building a better healthcare system through patient feedback.